MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.290
-0.040
-3.01%
After Hours: 1.290 0 0.00% 19:58 02/03 EST
OPEN
1.290
PREV CLOSE
1.330
HIGH
1.350
LOW
1.270
VOLUME
4.98M
TURNOVER
0
52 WEEK HIGH
4.530
52 WEEK LOW
1.090
MARKET CAP
282.36M
P/E (TTM)
-3.6627
1D
5D
1M
3M
1Y
5Y
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
Benzinga · 01/27 11:26
Ocugen Will Likely Need Large COVID Studies Going Forward
Seeking Alpha · 01/25 17:45
Insider Sell: Ocugen
Insider Sell: Ocugen
MT Newswires · 01/19 16:28
Ocugen: FDA Sector Head States Bridging Studies Insufficient
Seeking Alpha · 01/17 21:22
Noble Financial Reaffirms Their Buy Rating on Ocugen (OCGN)
TipRanks · 01/17 13:25
Mizuho Securities Reaffirms Their Buy Rating on Ocugen (OCGN)
TipRanks · 01/17 09:15
Exclusive: Top 10 Most Searched Tickers On Benzinga Pro In 2022 — Where Do SPY, Tesla, Apple And AMC Rank?
Benzinga · 01/09 21:34
Why Is Party City (PRTY) Stock Up 41% Today?
Investor Place · 01/09 16:49
More
About OCGN
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

Webull offers kinds of Ocugen Inc stock information, including NASDAQ:OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.